You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康寧醫院(02120.HK)擬收購樂清邦爾醫院100%股權 完善在浙江省的醫療服務體系
格隆匯 01-09 19:13

格隆匯1月9日丨康寧醫院(02120.HK)宣佈,公司近日與樂清邦爾中西醫結合醫院有限公司("樂清邦爾醫院")的股東邦爾骨科醫院集團股份有限公司("邦爾骨科")簽署股權收購協議,約定由公司收購邦爾骨科持有的樂清邦爾醫院100%的股權,收購基準價格為人民幣4,165萬元,並根據股權收購協議約定的交易結算軋差予以確定最終價格,最終價格不高於人民幣4,373萬元。股權收購完成後,公司將直接持有樂清邦爾醫院100%的股權,樂清邦爾醫院成為公司全資附屬公司。

截至公吿日期,公司就樂清邦爾股權變更事項正在辦理必要的變更登記手續。

據悉,樂清邦爾醫院是一家位於中國浙江省樂清市的營利性醫療機構,佔地面積約5,910平方米,建築面積約14,757平方米,現有物業最大可開放牀位450張。

公吿稱,此次收購對於完善集團在浙江省的醫療服務體系、擴大醫療服務供給規模具有戰略性作用。通過收購樂清邦爾醫院,一方面可以緩解公司旗下附屬公司樂清康寧醫院有限公司牀位緊張壓力,大幅提高集團在樂清地區精神科醫療服務能力及規模;另一方面可以藉助公司旗下附屬公司温州怡寧老年醫院有限公司成熟的老年康復醫療模式,整合醫際之間的優勢資源,提升區域整體盈利水準,進一步發展並鞏固集團在浙江南部地區的精神專科及老年康復醫療市場地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account